When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
PRAX - Praxis Precision Medicines: Genetic Medicines For Neurological Disease
Praxis Precision Medicines Inc.
Praxis is developing a potential first-in-class drug candidate, PRAX-114, in major depressive disorder.
With clinical catalysts coming up in early 2022 for PRAX-114, there is a window of opportunity to invest in the company.
Praxis also has a unique rare-to-common drug discovery platform that can enable a diverse pipeline across CNS disorders and significant biopharma partnerships.